Surface display of glycosylated Tyrosinase related protein-2 (TRP-2) tumour antigen on Lactococcus lactis

• Main Authors: Kalyanasundram, Jeevanathan, Suet, Lin Chia, Ai, Adelene Lian Song, Abdul Rahim, Raha, A., Howard Young, Yusoff, Khatijah
• Format: Article
• Language: English
• Published: BioMed Central 2015
• Online Access: http://psasir.upm.edu.my/id/eprint/46435/1/Surface%20display%20of%20glycosylated%20Tyrosinase%20related%20protein-2%20%28TRP-2%29%20tumour%20antigen%20on%20Lactococcus%20lactis.pdf; http://psasir.upm.edu.my/id/eprint/46435/

Background:The exploitation of the surface display system of food and commensal lactic acid bacteria (LAB) for bacterial, viral, or protozoan antigen delivery has received strong interest recently. The Generally Regarded as Safe (GRAS) status of the Lactococcus lactis coupled with a non-recombinant strategy of in-trans surface display, provide a safe platform for therapeutic drug and vaccine development. However, production of therapeutic proteins fused with cell-wall anchoring motifs is predominantly limited to prokaryotic expression systems. This presents a major disadvantage in the surface display system particularly when glycosylation has been recently identified to significantly enhance epitope presentation. In this study, the glycosylated murine Tyrosinase related protein-2 (TRP-2) with the ability to anchor onto the L. lactis cell wall was produced in suspension adapted Chinese Hamster Ovary (CHO-S) cells by expressing TRP-2 fused with cell wall anchoring LysM motif (cA) at the C-terminus. Results: A total amount of 33 μg of partially purified TRP-2-cA from ~6.0 g in wet weight of CHO-S cells was purified by His-tag affinity chromatography. The purified TRP-2-cA protein was shown to be N-glycosylated and successfully anchored to the L. lactis cell wall. Conclusions: Thus cell surface presentation of glycosylated mammalian antigens may now permit development of novel and inexpensive vaccine platforms.